NCT06815731

Brief Summary

In the laparoscopic lateral suspension (LLS) technique, the fixation of the mesh as a prosthetic element for correcting anterior apical vaginal prolapse at the level of the dome or uterus can offer anatomical and functional results that are not inferior to those of the conventional surgical technique, minimize possible intraoperative complications and facilitate the specific learning curve of sacropexy.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
181

participants targeted

Target at P75+ for not_applicable

Timeline
0mo left

Started Oct 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress98%
Oct 2023May 2026

Study Start

First participant enrolled

October 1, 2023

Completed
1.3 years until next milestone

First Submitted

Initial submission to the registry

January 30, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 7, 2025

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2025

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Expected
Last Updated

February 7, 2025

Status Verified

February 1, 2025

Enrollment Period

1.6 years

First QC Date

January 30, 2025

Last Update Submit

February 6, 2025

Conditions

Outcome Measures

Primary Outcomes (4)

  • Pelvic Organ Prolapse Distress Inventory

    Pelvic Organ Prolapse Distress Inventory (POPDI-6) Scores range between 0 and 24 for the POPDI-6

    up to 12 months

  • Colorectal-Anal Distress Inventory

    Colorectal-Anal Distress Inventory (CRADI-8) Scores between 0 and 32 for the CRADI-8

    up to 12 months

  • Urinary Distress Inventory

    Urinary Distress Inventory (UDI-6) Scores between 0 and 24 for the UDI-6.

    up to 12 months

  • Number of patients with symptomatic failure

    Number of patients with symptomatic failure , defined as a positive response (accompanied by any degree of discomfort) to the following question on the validated questionnaire regarding prolapse symptoms (PFDI-20): "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?"

    up to 12 months

Secondary Outcomes (2)

  • Intestinal and pain symptoms

    up to 12 months

  • Anatomical result

    up to 12 months

Study Arms (2)

lateral laparoscopic suspension (LLS)

EXPERIMENTAL
Procedure: lateral laparoscopic suspension (LLS)

Sacropexy without posterior mesh fixation on the puborrectalis muscle

ACTIVE COMPARATOR
Procedure: Sacropexy without posterior mesh fixation on the puborrectalis muscle

Interventions

lateral laparoscopic suspension (LLS)

lateral laparoscopic suspension (LLS)

Sacropexy without posterior mesh fixation on the puborrectalis muscle

Sacropexy without posterior mesh fixation on the puborrectalis muscle

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with Stage II- IV primary or recurrent prolapse affecting the anterior or middle vaginal compartment with or without minimal posterior defect (Stage I) according to the POP-Q.

You may not qualify if:

  • History of abdominal prolapse reconstructive surgery.
  • History of prolapse reconstructive surgery with vaginal meshes.
  • Stage I according to the POP-Q classification or asymptomatic prolapse.
  • Medical contraindication for general anaesthesia.
  • Patient preference for vaginal surgical treatment.
  • Patient does not wish to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

HCUVA

Murcia, 30120, Spain

RECRUITING

MeSH Terms

Conditions

Pelvic Floor Disorders

Condition Hierarchy (Ancestors)

Female Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesPregnancy ComplicationsMale Urogenital Diseases

Central Study Contacts

María Luisa Sánchez Ferrer, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 30, 2025

First Posted

February 7, 2025

Study Start

October 1, 2023

Primary Completion

April 30, 2025

Study Completion (Estimated)

May 30, 2026

Last Updated

February 7, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations